Müller-Thomas, C., Rudelius, M., Rondak, I., Haferlach, T., Schanz, J., Huberle, C., . . . Götze, K. (2014). Response to azacitidine is independent of p53 expression in higher-risk myelodysplastic syndromes and secondary acute myeloid leukemia. Ferrata Storti Foundation.
Chicago Style CitationMüller-Thomas, Catharina, et al. Response to Azacitidine Is Independent of P53 Expression in Higher-risk Myelodysplastic Syndromes and Secondary Acute Myeloid Leukemia. Ferrata Storti Foundation, 2014.
MLA CitationMüller-Thomas, Catharina, et al. Response to Azacitidine Is Independent of P53 Expression in Higher-risk Myelodysplastic Syndromes and Secondary Acute Myeloid Leukemia. Ferrata Storti Foundation, 2014.
Warning: These citations may not always be 100% accurate.